View in EDS HTML Full Text PDF Full Text

Ensifentrine Added on to Dual Bronchodilator or Triple Therapy Demonstrates Clinically Meaningful Improvement in CAT Score in Symptomatic Patients with Chronic Obstructive Pulmonary Disease.

Saved in:
Bibliographic Details
Title: Ensifentrine Added on to Dual Bronchodilator or Triple Therapy Demonstrates Clinically Meaningful Improvement in CAT Score in Symptomatic Patients with Chronic Obstructive Pulmonary Disease.
Authors: Siler TM; Midwest Chest Consultants, PC, Saint Charles, MO, USA., Rheault T; Verona Pharma, a Subsidiary of Merck & Co., Inc., Rahway, NJ, USA., Reyner D; Verona Pharma, a Subsidiary of Merck & Co., Inc., Rahway, NJ, USA., MacDonald-Berko M; Verona Pharma, a Subsidiary of Merck & Co., Inc., Rahway, NJ, USA., Davidson J; Stat One LLC, Cary, NC, USA., Rickard K; Verona Pharma, a Subsidiary of Merck & Co., Inc., Rahway, NJ, USA.
Source: International journal of chronic obstructive pulmonary disease [Int J Chron Obstruct Pulmon Dis] 2026 Feb 10; Vol. 21, pp. 589655. Date of Electronic Publication: 2026 Feb 10 (Print Publication: 2026).
Publication Type: Journal Article; Clinical Trial, Phase III; Case Reports; Clinical Trial
Journal Info: Publisher: DOVE Medical Press Country of Publication: New Zealand NLM ID: 101273481 Publication Model: eCollection Cited Medium: Internet ISSN: 1178-2005 (Electronic) Linking ISSN: 11769106 NLM ISO Abbreviation: Int J Chron Obstruct Pulmon Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41710324
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Ensifentrine Added on to Dual Bronchodilator or Triple Therapy Demonstrates Clinically Meaningful Improvement in CAT Score in Symptomatic Patients with Chronic Obstructive Pulmonary Disease.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Siler+TM%22">Siler TM</searchLink>; Midwest Chest Consultants, PC, Saint Charles, MO, USA.<br /><searchLink fieldCode="AU" term="%22Rheault+T%22">Rheault T</searchLink>; Verona Pharma, a Subsidiary of Merck & Co., Inc., Rahway, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Reyner+D%22">Reyner D</searchLink>; Verona Pharma, a Subsidiary of Merck & Co., Inc., Rahway, NJ, USA.<br /><searchLink fieldCode="AU" term="%22MacDonald-Berko+M%22">MacDonald-Berko M</searchLink>; Verona Pharma, a Subsidiary of Merck & Co., Inc., Rahway, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Davidson+J%22">Davidson J</searchLink>; Stat One LLC, Cary, NC, USA.<br /><searchLink fieldCode="AU" term="%22Rickard+K%22">Rickard K</searchLink>; Verona Pharma, a Subsidiary of Merck & Co., Inc., Rahway, NJ, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101273481%22">International journal of chronic obstructive pulmonary disease</searchLink> [Int J Chron Obstruct Pulmon Dis] 2026 Feb 10; Vol. 21, pp. 589655. <i>Date of Electronic Publication: </i>2026 Feb 10 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase III; Case Reports; Clinical Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22DOVE+Medical+Press%22">DOVE Medical Press </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>101273481 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1178-2005 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211769106%22">11769106 </searchLink><i>NLM ISO Abbreviation: </i>Int J Chron Obstruct Pulmon Dis <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41710324
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.2147/COPD.S589655
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 589655
    Titles:
      – TitleFull: Ensifentrine Added on to Dual Bronchodilator or Triple Therapy Demonstrates Clinically Meaningful Improvement in CAT Score in Symptomatic Patients with Chronic Obstructive Pulmonary Disease.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Siler TM
      – PersonEntity:
          Name:
            NameFull: Rheault T
      – PersonEntity:
          Name:
            NameFull: Reyner D
      – PersonEntity:
          Name:
            NameFull: MacDonald-Berko M
      – PersonEntity:
          Name:
            NameFull: Davidson J
      – PersonEntity:
          Name:
            NameFull: Rickard K
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 10
              M: 02
              Text: 2026 Feb 10
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1178-2005
          Numbering:
            – Type: volume
              Value: 21
          Titles:
            – TitleFull: International journal of chronic obstructive pulmonary disease
              Type: main
ResultId 1